GDF‐15 is associated with sarcopenia and frailty in acutely admitted older medical patients
Abstract Background Growth differentiation factor‐15 (GDF‐15) has been associated with senescence, lower muscle strength, and physical performance in healthy older people. Still, it is not clear whether GDF‐15 can be utilized as a biomarker of sarcopenia and frailty in the early stages of hospitaliz...
Saved in:
Main Authors: | Rikke S. Kamper (Author), Hanne Nygaard (Author), Louis Praeger‐Jahnsen (Author), Anette Ekmann (Author), Sisse Bolm Ditlev (Author), Martin Schultz (Author), Sofie Krarup Hansen (Author), Pernille Hansen (Author), Eckart Pressel (Author), Charlotte Suetta (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2024-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Changes in systemic GDF15 across the adult lifespan and their impact on maximal muscle power: the Copenhagen Sarcopenia Study
by: Julian Alcazar, et al.
Published: (2021) -
Associations between inflammatory markers, body composition, and physical function: the Copenhagen Sarcopenia Study
by: Rikke S. Kamper, et al.
Published: (2021) -
Sarcopenia and the syndrome of frailty
by: Ajay Kumar Gupta, et al.
Published: (2016) -
Frailty and Sarcopenia Recent Evidence and New Perspectives
Published: (2022) -
Frailty and Sarcopenia Onset, Development and Clinical Challenges
Published: (2017)